Critical analysis of the potential for microRNA biomarkers in breast cancer management

Breast cancer is a complex and heterogeneous disease. Signaling by estrogen receptor (ER), progesterone receptor (PR), and/or human EGF-like receptor 2 (HER2) is a main driver in the development and progression of a large majority of breast tumors. Molecular characterization of primary tumors has id...

Descripción completa

Detalles Bibliográficos
Autores principales: Graveel, Carrie R, Calderone, Heather M, Westerhuis, Jennifer J, Winn, Mary E, Sempere, Lorenzo F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346363/
https://www.ncbi.nlm.nih.gov/pubmed/25759599
http://dx.doi.org/10.2147/BCTT.S43799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346363/
https://www.ncbi.nlm.nih.gov/pubmed/25759599
http://dx.doi.org/10.2147/BCTT.S43799

Ejemplares similares